Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Other folate-dependent enzymes" refers to a heterogeneous group of enzymes within the one-carbon metabolism network that utilize folate derivatives as essential cofactors, excluding the primary targets dihydrofolate reductase (DHFR) and thymidylate synthase (TS) [PMID: 11560818]. This category encompasses enzymes such as glycinamide ribonucleotide transformylase (GART), aminoimidazole carboxamide ribonucleotide transformylase (AICARFT), and methylenetetrahydrofolate dehydrogenase (MTHFD), which are essential for the de novo synthesis of purine nucleotides [PMID: 10485309]. These enzymes facilitate the transfer of one-carbon units required for the biosynthesis of DNA, RNA, and amino acids like methionine and serine [PMID: 23430461]. In clinical oncology, multi-targeted antifolates like pemetrexed are designed to inhibit several of these enzymes simultaneously, thereby disrupting cellular proliferation more effectively than single-target agents [PMID: 12154053]. Because these metabolic pathways are fundamental to all rapidly dividing cells, pharmacological inhibition often leads to systemic toxicities such as myelosuppression, mucositis, and gastrointestinal distress [PMID: 15534355]. Consequently, these enzymes represent a significant area of research for developing more selective antimetabolites and understanding the metabolic dependencies of various cancers and autoimmune conditions.
Inhibition of enzymes involved in the transfer of one-carbon units, leading to the disruption of de novo purine and pyrimidine synthesis and subsequent inhibition of DNA and RNA production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other folate-dependent enzymes.